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Background: Lysosomes play important roles in multiple aspects of physiology, but the problem of how the
transcription of lysosomal genes is coordinated remains incompletely understood. The goal of this study was to
illuminate the physiological contexts in which lysosomal genes are coordinately regulated and to identify
transcription factors involved in this control.
Results: As transcription factors and their target genes are often co-regulated, we performed meta-analyses of
array-based expression data to identify regulators whose mRNA profiles are highly correlated with those of a core
set of lysosomal genes. Among the ~50 transcription factors that rank highest by this measure, 65% are involved in
differentiation or development, and 22% have been implicated in interferon signaling. The most strongly correlated
candidate was Stat6, a factor commonly activated by interleukin-4 (IL-4) or IL-13. Publicly available chromatin
immunoprecipitation (ChIP) data from alternatively activated mouse macrophages show that lysosomal genes are
overrepresented among Stat6-bound targets. Quantification of RNA from wild-type and Stat6-deficient cells
indicates that Stat6 promotes the expression of over 100 lysosomal genes, including hydrolases, subunits of the
vacuolar H+ ATPase and trafficking factors. While IL-4 inhibits and activates different sets of lysosomal genes, Stat6
mediates only the activating effects of IL-4, by promoting increased expression and by neutralizing undefined
inhibitory signals induced by IL-4.
Conclusions: The current data establish Stat6 as a broadly acting regulator of lysosomal gene expression in mouse
macrophages. Other regulators whose expression correlates with lysosomal genes suggest that lysosome function is
frequently re-programmed during differentiation, development and interferon signaling.Background
Cells must be able to flexibly adjust the structural and func-
tional capacity of their compartments in order to adapt to
stress or changing nutrients, to assume specialized tissue
functions and to maintain homeostasis.
The biogenesis of cellular organelles involves the assem-
bly and targeting of numerous proteins and membrane
lipids, and often these processes are orchestrated by tran-
scription factors whose activities are adjusted in response to
stress or developmental cues. While much is known regard-
ing the regulation of lipids, mitochondria, peroxisomes and* Correspondence: a.nohturfft@sgul.ac.uk
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reproduction in any medium, provided the orthe ER [1-6], understanding the transcriptional regulation
of lysosomal function remains less advanced.
Lysosomes are defined by acidic luminal pH, characteris-
tic membrane proteins and lipids, and the presence of mul-
tiple acidic hydrolases that catalyze the degradation of
material reaching the compartment through fluid-phase
endocytosis, phagocytosis or autophagy [7-10]. Abnormal-
ities of lysosomal function, content, number, morphology
or gene expression are characteristic of multiple inherited
lysosomal storage diseases, of cellular senescence, organis-
mal ageing, atherosclerosis, Alzheimer’s and other neurode-
generative diseases [11-17]. Ectopic secretion of lysosomal
proteases can lead to excessive extracellular matrix degrad-
ation, which in turn contributes to metastasis, emphysema,
atherosclerosis, arthritis, osteoporosis and the formation of
aneurysms [14,18-20].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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shown that a number of lysosomal genes form coordinated
clusters, or synexpression groups, suggesting that expres-
sion of these targets is co-regulated under varying condi-
tions [21-23]. Sardiello et al. performed a pattern search of
lysosomal promoters, leading to the identification of a spe-
cific E-box, which was found to be recognized by a basic
helix-loop-helix transcription factor called TFEB [21,23].
Ectopically expressed TFEB causes an upregulation of mul-
tiple lysosomal genes, leading to increased numbers of lyso-
somes, enhanced degradation of endocytic substrates, and
lysosomal exocytosis [21,24].
Transcriptional regulation of lysosomal function has
been studied mainly during autophagy, and in this con-
text several transcription factors have been shown to
play roles in lysosomal gene regulation, including GATA-1
[25], FoxO3 [25] and TFEB [26-29].
Lysosomal substrates of extracellular origin impose a
particular load on macrophages and other phagocytic
myeloid cells that process microbes, senescent cells and
effete tissue material [11,30]. How the degradative cap-
acity of lysosomes in such cells is regulated during stress
and differentiation remains poorly understood.
Here, we used expression correlation analyses to
search for novel regulators of lysosome-specific genes.
We found that transcription factors whose expression
correlates with lysosomal genes are often involved in dif-
ferentiation, embryonic development and interferon sig-
naling. The strongest candidate that emerged from our
computations was Signal Transducer and Activator of
Transcription-6 (Stat6), a transcription factor regulated
by IL-4 and IL-13. The roles of IL-4 and Stat6 in modu-
lating lysosomal gene expression were evaluated in a pri-
mary cell culture model of alternatively activated mouse
macrophages using data based on gene expression profil-
ing, quantitative PCR and chromatin immunoprecipita-
tions. Results obtained with macrophages from wild-type
and Stat6-deficient mice demonstrate that Stat6 posi-
tively regulates a large number of lysosomal genes in an
IL-4-dependent manner.
Results
Identification of transcriptional networks through
correlation analysis
Previous studies have shown that the mRNA levels of
transcriptional regulators are often predictive of the ex-
pression of their target genes [31-36]. Based on this
premise, we asked whether mRNA correlation analyses
across multiple datasets might reveal novel regulators of
lysosomal gene expression.
Calculations were performed using expression profiles
based on specific mouse and human Affymetrix micro-
array platforms for which large numbers of independent
datasets are available at the NCBI GEO repository [37].We then processed these files to generate average ex-
pression values for named, full-length mRNAs. A list of
known transcription factors was assembled from gene
ontology (GO) annotations and the literature [38,39].
To verify the usefulness of the processed expression
data for extracting transcriptional regulators, we initially
interrogated the datasets for two pathways whose regula-
tion is already well understood. We began by calculating
a matrix of Pearson correlations between 19 mouse
genes in the cholesterol biosynthesis pathway and 1,683
known transcription factors. The results were aggregated
according to transcription factor and ranked. The result-
ing list was led by Srebf2, which encodes the transcrip-
tion factor SREBP-2, known in fact to be a pivotal
regulator of cholesterol metabolism and of the genes in
the reference set (Figure 1A; Additional file 1) [6,40].
To further trial this strategy on a pathway for organelle
biogenesis, we selected a group of 97 highly coordinated ER
genes and found that this cluster correlates most strongly
with Xbp1, an established master regulator of the ER stress
response and of ER biogenesis (Figure 1B; Additional files
1, 2 and 3) [4].
In a complementary approach, Srebf2 and Xbp1 were
each used as reference to calculate expression correla-
tions with 16,771 mouse genes. Of the 10 genes that cor-
related most strongly with Srebf2, five are involved in
cholesterol metabolism (p = 2.8E-09, hypergeometric test),
and of the 10 genes most strongly correlated with Xbp1
nine encode proteins associated with the ER (p = 3.2E-10)
(Additional file 4). These values are similar to results
returned by the Netview tool, which returns lists of
‘nearest neighbors’ based on co-occurrence in expres-
sion quantile groups [22]; according to Netview, the sets
of 10 nearest neighbors for Srebf2 and Xbp1 each in-
clude five genes associated with cholesterol metabolism
or the ER, respectively (data not shown). Taken to-
gether, the above results confirm that correlation ana-
lyses of co-regulated gene groups across our processed
datasets can identify transcription factors that coordin-
ate their expression.
Correlation analysis of lysosomal gene expression
We next asked which transcription factors might correlate
with the expression of lysosomal genes. Calculations were
performed for 1066 mouse and 1412 human DNA-binding
transcription factors for which high-quality data are avail-
able in the processed microarray datasets. In each case the
500 highest-ranking correlators were then analyzed for GO
set enrichment using the Bioconductor GOstats package
[41]. The resulting tables were searched for the terms ‘lyso-
some’ or ‘vacuole’, returning 49 transcription factors that
scored positive at a significance cutoff of p ≤ 0.001 and
according to both mouse and human datasets (Additional
file 5; a searchable database of the complete results is
A. Cholesterol biosynthesis 
B. Endoplasmic reticulum
Figure 1 Gene expression correlation analyses identify
transcriptional regulators in the endomembrane system.
Analyses are based on 1,517 sets of publicly available mouse
microarray expression profiles (Affymetrix Mouse_430_2 arrays) that
were processed as described in Methods [37]. (A) Pearson
correlations were calculated between 19 cholesterol biosynthesis
reference genes and a list of 1,683 known transcription factors
[6,38,39]. Average correlation coefficients were calculated for each
transcription factor. (B) Average correlations across datasets were
calculated among a list of 778 ER-specific genes (Additional file 2).
Hierarchical clustering was performed and the resulting dendrogram
split into 6 clusters (Additional file 3). The cluster with the largest
average, consisting of 97 ER genes, was then used to calculate corre-
lations with known transcription factors as in (a). (A,B) Prior to calcu-
lating correlations with transcription factors, datasets were filtered to
exclude those with an average coefficient of variation of less than
30% for the respective reference set such that only the indicated
number n of data series were included for final analyses. Each plot
shows the results for the 10 highest-ranking transcription factors;
only DNA-binding proteins (GO:0003677) are shown. Complete results
are given in Additional file 1.
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tional regulators include two factors, MITF and TFEB, that
have previously been shown to direct the expression of
lysosomal genes during differentiation and autophagy, re-
spectively [26-29,42]. Further validating the data is the pres-
ence of 7 regulators that are known to physically associate
with the endomembrane system (ATF6, HCLS1, LASS2,
CREB3, NFE2L1, NFE2L2, and TSG101). A majority (65%),
however, have been implicated during embryonic develop-
ment or differentiation (CEBPA, CEBPB, CEBPD, DDIT3,
EGR2, EPAS1, FOS, HCLS1, HDAC5, HHEX, IKZF1, IRF1,IRF8, LMO2, LYL1, MAF, MAFB, MAFG, MITF, MNT,
NFE2L2, NR1H2, NR1H3, PPARG, RELA, SPIB, STAT1,
STAT3, STAT5A, STAT6, TFEB, TSG101). Also prominent
are transcription factors involved in interferon signaling
(CIITA, IRF1, IRF2, IRF5, IRF8, IRF9, NR1H2, NR1H3,
PPARG, STAT1, STAT2).
The above results suggest that lysosomal gene sets are re-
programmed in the context of different transcriptional net-
works. We therefore sought to identify subsets of lysosomal
genes that are likely to be coordinately regulated. Correla-
tions were calculated among a list of 269 lysosomal genes
that had been assembled from GO annotations and reviews
of the lysosomal proteome [38,43,44]. Computations were
performed across 1,444 mouse datasets, and the genes were
clustered hierarchically according to average correlation co-
efficients. Inspection of the resulting dendrogram and heat
map identify three principal clusters, suggesting that the
genes in each of these groups are often controlled collect-
ively (Figure 2; Additional files 6 and 7).
Cluster 1 consists of 38 genes encoding lysosomal pro-
teins whose functional profiles are generally similar to
that of the entire lysosomal gene set. However, an unex-
pectedly large number of Cluster 1 genes (58%) have also
been found at the plasma membrane (GO:0044459) or
extracellularly (GO:0005576); of lysosomal genes outside
of cluster 1, only 33% fall into either of these categories.
Cluster 2 consists of 41 genes that cover a range of dif-
ferent lysosomal functions, but subunits of the vacuolar
H+ ATPase (Atp6ap2, Atp6v1a, Atp6v1b2, Atp6v1c1,
Atp6v1d, Atp6v1g1, Atp6v1h) and components of the
endo/lysosomal trafficking machinery (Lamp2, M6pr,
Rab14, Rab7, Rab9, Snap23, Vamp7, Vps4b) are particu-
larly prominent. The expression of genes in Cluster 1 is
correlated negatively with 78% of Cluster 2, suggesting
that these gene sets are frequently regulated reciprocally.
Cluster 3, the largest coherent group, includes 128
lysosomal genes whose protein products are involved in
all aspects of lysosome physiology, including hydrolysis,
acidification, transport and antigen presentation.
Collectively, the preceding analyses support the con-
clusion that distinct subsets of lysosomal genes can be
coordinately regulated, hinting at the existence of dedi-
cated transcriptional networks that control the expression
of these clusters. The relatively low average correlation
values indicate that such networks would be active only in
a subset of physiological contexts.
Transcription factors co-regulated with lysosomal
syn-expression groups
Next, in order to explore the contexts and possible regula-
tion of the three lysosomal gene clusters, each group was
used as reference set for correlation analyses with known
transcription factors across both mouse and human data-
sets. The complete results of these calculations are given in
Figure 2 Gene expression correlation analysis identifies distinct subsets of lysosomal genes. Pearson correlation coefficients across 1,444
Mouse430_2-based microarray datasets were calculated among a list of 269 lysosomal genes that had been selected based on GO annotations
(GO:0005764) and reviews of the lysosomal proteome [38,43,44]. The resulting data matrix (Additional file 6) was clustered, displayed as a heat
map and the dendrogram split into branches as described in Methods. Clusters discussed in the main text are indicated.
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factors are listed in Figure 3.
A large proportion of the transcription factors that correl-
ate with Cluster 1 are known to play roles in embryonic de-
velopment and morphogenesis (CRX, GRHL2, HNF1A,
HOXC6, MESP2, PAX8, SIM1, SMYD1, TBX19, TBX6;
GO:0032502). Based on Pubmed literature searches, none
have been associated with the regulation of lysosomal orvacuolar function. Two genes, Pax8 and Smyd1, are com-
mon to both the mouse and human top-10 lists. Pax8 is
important for thyroid and kidney development [45,46].
Twenty-nine percent of Cluster 1 genes (Aldob, Aqp2,
Atp6v0a4, Atp6v1b1, Atp6v1c2, Cckar, Cubn, Dnase1,
Kcne1, Slc30a2, Sult1c2) are highly expressed in mouse kid-
ney (> 2 standard deviations above the mean) [47], which
may help explain the moderate correlation of Pax8 with the
Figure 3 Correlation of lysosomal clusters with transcription factors. Lysosomal gene clusters identified in Figure 2 were used as reference
sets for correlation analyses with known transcription factors as in Figure 1. Left panels, Mouse430_2 datasets. Right panels, human
HG_U133_Plus2 datasets. Each plot shows the results for the 10 highest-ranking transcription factors; only DNA-binding proteins (GO:0003677) are
shown. Complete results are given in Additional file 7.
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heart-specific histone methyltransferase, also known as
Bop, that acts as a transcriptional repressor [48,49].
Whether Smyd1 contributes to the repression of the lyso-
somal Cluster 2 genes is currently not known.
Five of the top-10 transcription factors that correlate with
Cluster 2 (NFE2L2, HBP1, XBP1, HIF1A, CTNNB1) have
been linked to both oxidative stress and autophagy. The
intersection of the mouse and human regulators contains
three genes (NFE2L2, HBP1 and RNF6), with NFE2L2
ranking highest. The NFE2L2 gene encodes the protein nu-
clear factor-erythroid 2-related factor 2 (Nrf2), a basic-
leucine zipper transcription factor that activates genes with
antioxidant response elements (AREs) under conditions of
oxidative stress [50]. Based on published chromatin
immunoprecipitation-sequencing (ChIP-Seq) data from
mouse embryonic fibroblasts (MEFs), Nrf2 binds to the
promoters of five of the cluster 2 genes (CD164, CLN5,
CTSO, SCPEP1, TMEM55A) (p = 0.014, hypergeometric
test) and to eight additional lysosomal genes [51]. In lymph-
oid cells Nrf2 binds to the promoter of one of the cluster 2
genes (IDS) plus nine other lysosomal genes [52], with
FNBP1 and GABARAPL1 being recognized in both MEFsand lymphoid cells. According to published microarray
studies comparing wild-type and Nrf2-deficient mouse tis-
sues, the expression of only a small and varying number of
Cluster 2 genes are affected by Nrf2 in liver, small intestine
and prostate [53-56]. Consistent across independent studies
is the Nrf2-dependent regulation of Ctsb (cathepsin B) in
liver, small intestine and prostate [54,56]; moreover, Nrf2
binds close to the Scpep1 (serine carboxypeptidase 1) gene
in MEFs and regulates its expression in liver and small in-
testine [51,54]. In summary, Nrf2 regulates a small number
of lysosomal genes in a tissue-specific manner, but available
evidence does not yet support the concept that Nrf2 ac-
counts for the coordinate regulation of a majority Cluster 2
genes.
The transcription factor whose expression profiles cor-
related most strongly with those of the lysosomal Cluster
3 was mouse Stat6, and following an analogous analysis
of human datasets, STAT6 ranked near the top as well
(Figure 3). Also correlating strongly with Cluster 3 are
other regulators of immune function (Irf3, Nr1h2, Rela,
Stat2, Stat3) and transcription factors bound to the
membrane of the ER (Atf6, Creb3, Creb3l2, Lass2,
Nfe2l1).
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cluster, Stat6 was chosen for further in-depth analyses.
Stat6
As a cutoff-free approach to identifying which GO cat-
egories best correlate with Stat6 we used the Gene Set
Enrichment Analysis (GSEA) tool developed by Subra-
manian et al. [57]. GSEA calculates enrichment scores
that reflect to what degree members of a particular GO
category are concentrated at the extreme of a ranked
gene list. The method also defines a ‘leading-edge’ subset
of genes that account for the core of the enrichment
score. The greatest enrichment scores for genes that cor-
relate with mouse Stat6 were seen for the GO terms
‘lysosomal membrane’ and ‘lysosome’ (nominal p = 0;
Figure 4B and C; Additional file 8). In the human data-
sets the highest-scoring categories are related to type I
interferon and Toll-like receptor signaling; however,
the GO sets ‘lysosomal membrane’ and ‘lysosome’ also
ranked high (nominal p = 0; Figure 4G and H; Additional
file 8). The ‘leading-edge’ subsets for the GO term ‘lyso-
some’ contained 134 mouse and 126 human lysosomal
genes, respectively (Figure 4C and H), of which 98 were
common to both sets (73-78% overlap; Additional file 8).A.
B.
F
G
H
JE.
C.
D. I
Figure 4 Correlation of Stat6 with lysosomal genes. Average expression
calculated between Stat6 and each of (A) 16,771 genes represented on Aff
HG_U133_Plus2 arrays (see Methods). Only datasets with a coefficient of va
Genes were sorted according to correlation values, and the ranked lists we
matrix transposed (gmt) format were generated by reformatting lists, down
and human GO associations (all gene product types and data sources) [38]
Additional file 8. (A,F) Average expression correlations with Stat6. (B,G) Run
some’ (GO:0005764; 236 and 230 genes in mouse and human gene sets, re
score and delimit the ‘leading-edge’ set of genes that account for the enric
Barcode plots indicate the positions of lysosomal genes along the rank lists
in IL-4 treated mouse macrophages (see Figure 5 and Additional file 9). (E,
based on data deposited by Ostuni et al. (2013) [58] (see main text). LinesThese results confirm that Stat6 mRNA levels are often
coordinated with those of multiple lysosomal genes.
IL-4 and Stat6 regulate lysosomal gene expression in
macrophages
Stat6 is a member of the ‘signal transducer and activator
of transcription’ family and expressed in most tissues
[47,59]. The principal activators of Stat6 are IL-4 and IL-13,
whose binding to cognate receptor complexes leads
to recruitment of JAKs and JAK-mediated Stat6 phos-
phorylation, whereupon Stat6 dimerizes, moves to the
nucleus and binds to specific promoter elements [60,61].
In addition to being stimulated by IL-4 and IL-13, Stat6
can become active in response to other cytokines and
certain pathogens [60,62,63]. To obtain a detailed view
of lysosomal gene regulation by IL-4 and Stat6, we ana-
lyzed IL-4-induced changes of gene expression in macro-
phages from wild-type and Stat6-deficient mice [64].
Detailed results are given in Additional file 9 and are
graphically summarized in Figure 5. In the absence of
IL-4 the Stat6 genotype had no effect on lysosomal gene
expression, as would have been expected. However, in
cells exposed to IL-4 an absence of Stat6 was associated
with significant (p ≤ 0.05) changes in the expression of.
.
.
.
.
correlations across the indicated number (n) of datasets were
ymetrix Mouse_430_2 arrays and (F) 17,236 genes represented on
riation for Stat6 expression of at least 5% were used for analyses.
re analyzed using the GSEA tool [57]. Gene set reference files in gene
loaded from the AmiGO gene ontology website, containing all mouse
. Complete results of GSEA and GOstats statistics are given in
ning-sum enrichment scores for association with the gene set ‘lyso-
spectively); arrows indicate the position of the maximum enrichment
hment signal associated with the GO term ‘lysosome’ [57]. (C,H)
. (D,I) Ranks of lysosomal genes that are positively regulated by Stat6
J) Ranks of lysosomal gene loci bound by Stat6 in mouse macrophages
in barcode plots are drawn at 40% transparency.
A. D.
C.B.
Figure 5 Effects of IL-4 exposure and Stat6 deficiency on lysosomal gene expression in mouse macrophages. Analyses are based on
gene microarray data that have been previously described [64] [GEO:GSE25088]. RNA was from wild-type or Stat6-deficient mouse bone marrow
macrophages cultured in triplicate for 10 days with 20 ng/ml M-CSF minus or plus 20 ng/ml IL-4. Gene expression profiles were obtained with
Affymetrix Mouse_430_2 chips. Here, raw data were background-corrected, normalized and converted to log (base 2) fold changes as described
in Methods. Detailed results are given in Additional file 9. (A-C) Venn diagrams were generated using Biovenn [65]. (D) Heat map indicating
expression levels for lysosomal genes decreased at least two-fold in Stat6−/− versus Stat6+/+ macrophages grown in the presence of IL-4. Log
(base 2) changes in expression are given relative to those in wild-type cells grown without IL-4.
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expression in Stat6-deficient versus wild-type cells, 46
lysosomal genes were increased and 103 lysosomal genes
were decreased (Additional file 9).
The 103 lysosomal genes that are positively regulated by
Stat6 encode proteins involved in all aspects of lysosomal
function, including 39% of known lysosomal hydrolases,
most subunits of the vacuolar H+ ATPase, components of
the vesicular transport machinery and others (Figure 5A).
Of these 103 genes, 53% are among the leading edge of
mouse lysosomal genes whose expression correlates most
significantly with Stat6 (Figure 4D; p = 0.031).
In wild-type macrophages exposed to IL-4, fifty-one
lysosomal genes were induced and 60 lysosomal genes
were suppressed (Figure 5B and C), reflecting a complex
reconfiguration of gene expression in this cell type
[58,64]. The contribution of Stat6 to lysosomal gene ex-
pression, however, is generally positive: in Stat6-deficient
cells the activating effects of IL-4 were almost com-
pletely abolished (Figure 5B), whereas the suppressing
effects of IL-4 largely persisted (Figure 5C). Surprisingly,
82 lysosomal genes were suppressed by IL-4 in Stat6-
deficient, but not in wild-type cells (Figure 5C), indicat-
ing that Stat6 usually antagonizes the inhibitory effect of
IL-4 on the expression of these genes.
Next we sought to verify the microarray data through an
alternative method. For this, we cultured bone marrowmacrophages from wild-type and Stat6-deficient mice with
IL-4 for 6 hours, 24 hours or 10 days, and RNA was ex-
tracted for reverse transcription and quantitative PCR.
Most targets were chosen from among the lysosomal genes
that, according to Figure 5D, were decreased at least two-
fold in Stat6−/− versus Stat6+/+ macrophages grown in the
presence of IL-4. Expression of the Ppia gene (encoding
cyclophilin A) remained relatively unchanged under the
four conditions and was used to normalize values for the
remaining genes. The Arg1 gene (encoding arginase I), an
established target of IL-4/Stat6 signaling [66,67], was
strongly induced by IL-4 in wild-type cells, but its expres-
sion remained low in Stat6-deficient cells (Figure 6). Similar
results were obtained for most of the lysosomal genes that
were analyzed, with the strongest regulation by IL-4 seen
for Mmp13, Acp5, Ctsk, Atp6v0d2, Ifi30 and Ctsl. Only
Myo7a and Hgsnat, which appeared moderately induced by
IL-4 based on microarray analyses (Figure 5D), changed
much less significantly according to the qPCR data (data
not shown). Overall, however, the qPCR results are in good
agreement with the microarray data and confirm that IL-4
controls the expression of multiple lysosomal genes in a
Stat6-dependent manner.
Stat6 binds close to lysosomal gene loci
To explore whether Stat6 might bind to genomic loci en-
coding lysosomal genes, we interrogated publicly available
Figure 6 Effects of IL-4 and Stat6 on lysosomal gene expression
as measured by quantitative PCR. RNA was obtained from
triplicate cultures of wild-type or Stat6-deficient mouse bone mar-
row macrophages. For the panels in columns 1 and 2 macrophages
were cultured for 5 days with 20 ng/ml M-CSF and then with 20 ng/ml
IL-4 for an additional 6 or 24 hours as indicated. The data in column
3 were obtained from cultures grown ± M-CSF and IL-4 for 10 days
as in Figure 5. RNA was reverse transcribed and analyzed by quantitative
PCR as described in Methods. Oligonucleotides are listed in
Additional file 13.
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ing to peak coordinates from macrophages grown with IL-4
for 4 hours, Stat6 binds in the vicinity of 4,520 named
genes (± 5 kb of transcription start site), 153 of which have
been annotated as encoding lysosomal proteins (p = 6E-62,
hypergeometric test).
As an unbiased approach to determining whether genes
associated with specific functions are statistically over-
represented among the 4,520 Stat6-bound targets, the
list was subjected to gene set enrichment analysis using
GOstats [41]. Excluding categories with more than 1000
members, the three highest-ranking categories returned
by this analysis were ‘ribosomal subunit’ (GO:0044391;
p < 6E-11), ‘cytosolic part’ (GO:0044445; p < E-10) and
‘lysosome’ (GO:0005764; p < 2E-10) (Additional file 10).
These data indicate that genes encoding lysosomal pro-
teins make up a significant fraction of the genomic loci
that Stat6 physically interacts with.
Of the 153 lysosomal genes whose loci are bound by
Stat6 according to the current measure, 46% are among
the genes whose mRNA levels were significantly reduced
in Stat6-deficient macrophages grown with IL-4 (see
Figure 5 and Additional file 9). However, this fraction
increases to 72% if Stat6 peaks located anywhere inside
a gene are also counted as targets.
In order to study the kinetics of Stat6 binding to lyso-
somal loci, Stat6 ChIP-seq peaks from different time
points after IL-4 addition were aligned to genomic maps
of the genes whose mRNA levels were analyzed in
Figure 6. As expected, no IL-4 induced Stat6 binding
could be seen around the Ppia locus, whereas several
Stat6 peaks appeared at the Arg1 gene as early as
15 min after IL-4 addition (Figure 7). Similarly, IL-4
rapidly induced the binding of Stat6 to all of the 10
lysosomal genes that are shown, and binding patterns
remained relatively stable for the subsequent 4 hours.
At the Atp6v1h, Ctsl and Ifi30 loci additional Stat6 peaks
appear at later time points, suggesting contributions of
co-factors whose activities might increase with delayed
kinetics. To independently verify the Stat6 ChIP-seq data,
several peaks were selected for verification by ChIP-qPCR,
and in each case the results were confirmatory (Additional
file 11). Collectively, mRNA quantifications and ChIP-seq
data show that Stat6-mediated activation of lysosomal
Figure 7 (See legend on next page.)
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(See figure on previous page.)
Figure 7 Stat6 binds to lysosomal gene loci in mouse macrophages. Analyses are based on publicly available ChIP-seq data deposited by
Ostuni et al. (2013) [GEO:GSM1022294, GSM1022295, GSM1022296, GSM1022297, GSM1022298, GSM1022299, GSM1022300, GSM1022301,
GSM1022302, GSM1022303, GSM1022304, GSM1022305] [58]. In that study mouse bone marrow-derived macrophages were grown with IL-4 for
the indicated time, chromatin was immunoprecipitated with antibodies against Stat6 or H3K27ac, and the DNA fragments were sequenced. Here,
data files with peak coordinates were annotated and aligned to selected genomic loci as described in Methods. Coding regions of the indicated
genes are shown in blue, with the direction of transcription indicated by arrow heads. In some cases, neighboring genes or transcript variants
were omitted for clarity. Peak regions for Stat6 and H3K27ac are shown in orange and green, respectively.
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the affected promoters, strongly suggesting that Stat6
plays a direct role in augmenting the transcription of
these targets.Stat6 sites at lysosomal genes are near active chromatin
Actively transcribed genes are often controlled through
promoter and enhancer elements characterized by binding
sites for multiple, tissue-specific transcription factors and
by the presence of nucleosomes with activating epigenetic
modifications such as monomethylated histone H3 lysine-4
(H3K4me1) and acetylated H3 lysine-27 (H3K27ac) [68,69].
In macrophages, cell type-specific gene expression depends
in part on Pu.1, an ETS-domain transcription factor re-
quired for the development of myeloid and B-lymphoid cell
types [70-72]. Pu.1 has previously been shown to cooperate
with Stat6 in controlling the expression of several genes
[61]. To characterize Stat6-bound genomic regions near
lysosomal genes, we studied publicly available ChIP-seq
data to explore the co-localization of Stat6 with H3K4me1,
H3K27ac and Pu.1 in samples from wild-type and Stat6-
deficient macrophages that had been grown ± IL-4 for
4 hours [58]. As a point of reference we selected 196 Stat6
peaks that were observed consistently after 1, 2 and 4 hours
of IL-4 exposure and within 5 kb of the transcription start
sites of lysosomal genes (133 lysosomal genes; range, 1–4
peaks per gene; average, 1.5 peaks per gene) (Additional
file 12). Of these 196 peaks, 75% were marked by the
presence of H3K4me1, H3K27ac and Pu.1 in wild-type
cells grown without IL-4, showing that Stat6 predomin-
antly binds to regions characterized by activating epi-
genetic markers (Figure 8 and Additional file 12).
In macrophages, latent enhancers have been defined
as sites devoid of H3K4me1, H3K27ac and Pu.1 that
acquire H3K4me1 upon stimulation [58], and none of the
Stat6 peaks near lysosomal genes fall into this category
(Additional file 12).
Enhancer elements containing H3K4me1, but no
H3K27ac, have been described as “poised” for activation
[73,74]. Among the regions bound by Stat6 near lysosomal
genes, 86% (169/196) have pre-existing nucleosomes con-
taining H3K4me1, but only 4% (8/196) contain H3K4me1
alone and acquire H3K27ac upon IL-4 exposure; at 5 of
these sites (near Atp6v0d2, Htt, Ids, Plekhf1, Srgn) the IL-4induced acetylation of H3K27 was dependent on Stat6
(Figure 8 and Additional file 12).
H3K27ac marks are usually concentrated near pro-
moters and their presence is predictive of gene expres-
sion [75]. Inspection of the data in Additional file 12
shows that 89% (174/196) of the lysosomal Stat6 peak
regions already contain H3K27ac in untreated wild-type
cells. We identified 9 lysosomal Stat6 peak regions at
which H3K27ac was induced by IL-4, and this modifica-
tion was Stat6-dependent near the same 5 genes at
which IL-4/Stat6 promote monomethylation of H3K4
(Atp6v0d2, Htt, Ids, Plekhf1, Srgn), indicating that Stat6
coordinates activating chromatin modifications at these
promoters. Two of the affected targets, Atp6v0d2 and
Plekhf1, are among the lysosomal genes whose mRNA
levels are most strongly regulated by IL-4 and Stat6
(Figures 5, 6, 7 and 8). At many of the lysosomal genes
whose expression is controlled by Stat6, IL-4 exposure led
to a pronounced expansion of pre-existing H3K27ac marks
around the Stat6 peaks (e.g. Arg1, Plekhf1, Atp6v0a1,
Atp6v1b2, Atp6v1h, Ctsl, Acp5), and at most of these sites
the spreading of H3K27ac was dependent on Stat6
(Figures 7 and 8). In summary, Stat6 binds near lysosomal
genes at sites marked by active chromatin configurations,
and at several lysosomal genes Stat6 contributes to the
establishment or expansion of these markers. These
results further strengthen the concept that Stat6 plays
pivotal roles in activating the expression of lysosomal
genes in macrophages.
Discussion
In the current study we used gene expression correlation
analyses to search for DNA-binding transcription factors
whose activities might relate to lysosomal function. The
strongest candidate that emerged from our data was
Stat6, a widely expressed transcription factor that is acti-
vated in response to specific cytokines and pathogens. In
support of a role for Stat6 upstream of lysosomal gene
expression we demonstrate that IL-4 induced Stat6 posi-
tively regulates a wide range of lysosomal genes in
mouse macrophages.
Our in silico strategy was based on a large body of
work showing that the expression of transcription fac-
tors and their target genes are often positively related
[31-36]. If the expression of a group of lysosomal genes
Figure 8 (See legend on next page.)
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Figure 8 Effects of IL-4 and Stat6 on chromatin modifications near lysosomal genes. Analyses are based on publicly available ChIP-seq data
deposited by Ostuni et al. (2013) [GEO:GSM1022256, GSM1022257, GSM1022258, GSM1022259, GSM1022264, GSM1022265, GSM1022266,
GSM1022267] [58]. In that study bone marrow-derived macrophages from wild-type and Stat6-deficient mice were grown ± IL-4 for 4 hours, chro-
matin was immunoprecipitated with antibodies against Pu.1, H3K27ac and H3K4me1, and the DNA fragments were sequenced. Here, peak coordi-
nates were annotated and aligned to selected genomic loci as in Figure 7. Peak regions are shown in orange (Stat6), red (Pu.1), green (H3K27ac)
and purple (H3K4me1). Genomic regions and scales correspond to those shown in Figure 7.
Brignull et al. BMC Genomics 2013, 14:853 Page 12 of 20
http://www.biomedcentral.com/1471-2164/14/853was transcriptionally coordinated through the action of a
transcription factor, we reasoned, it might be possible to
identify such a regulator through correlation analyses
across a great number of microarray data. Association of
transcriptional regulators with their target genes, based
on expression data, has previously been demonstrated
using a number of methods, including mutual informa-
tion scoring [33,76], probabilistic methods [34], differen-
tial equations [77], Gibbs sampling [78] and Spearman
correlations [31]. Here, we applied a simplified clustering
approach by calculating Pearson correlations between
lists of known transcription factors and potential target
genes. Correlation values were averaged across hundreds
of expression datasets, and genes were ranked accord-
ingly. In one round of calculations genes most highly
correlated with individual known transcription factors
were screened for GO set enrichment which, at a cutoff
of p ≤ 0.001, produced a list of 49 DNA-binding regula-
tors whose expression is highly correlated with lyso-
somal genes. In a complementary approach transcription
factors were sorted according to their correlation with
groups of co-regulated lysosomal genes.
The list of 49 regulators includes MITF and TFEB,
two proteins that have been previously identified as reg-
ulators of lysosomal gene expression in the context of
autophagy, and differentiation [26-29,42]. Further valid-
ating our approach was the presence of proteins that are
known to be physically associated with compartments of
the endomembrane system, including ATF6, HCLS1,
LASS2, CREB3, NFE2L1, NFE2L2, and TSG101. Strik-
ingly, 65% of the 49 regulators have been implicated
during embryonic development or differentiation, and
22% are involved in interferon signaling, suggesting that
these processes are frequently accompanied by reconfig-
uration of the lysosomal system. Augmented expression
of lysosomal genes during development and differentiation
might support the generation of tissue-specific, lysosome-
related organelles [79]. Moreover, endo/lysosomal factors
are increasingly being implicated during cell migration
and polarity, both important aspects of development, as
well as of wound healing and cancer [80]. Positive correl-
ation between lysosomal and interferon signaling genes
points to the front-line role of lysosomes in the defense
against pathogens [81-83].
Cluster analysis of all known lysosomal genes led to
the identification of several subgroups whose expressionappears to be coordinated. Unexpectedly, one cluster
was characterized by being correlated negatively with a
large fraction of other lysosomal genes, indicating that
the expression of these groups is often mutually exclu-
sive. The mechanistic origin and physiological relevance
of these results is not yet understood. The largest lyso-
somal cluster includes large fractions of known acidic
hydrolases and vacuolar H+ ATPase subunits, supporting
the impression from previous studies that core lysosomal
functions are transcriptionally coordinated [21-23]. The
transcription factor most strongly correlated with this
cluster was Stat6. A member of the signal transducer
and activator of transcription family [84], Stat6 is acti-
vated predominantly through JAK-mediated tyrosine
phosphorylation in response to IL-4 or IL-13. Stat6-
deficient mice are viable, but suffer defects in the differ-
entiation of several immune and non-immune cell types,
exhibit increased susceptibility to infection by certain
viral, bacterial and helminthic pathogens and show at-
tenuated allergic responses [61]. Conversely, ectopically
activated Stat6 is frequently found in tumor samples
[85-87].
In monocytes, Stat6 signaling promotes the differenti-
ation into a class of alternatively activated macrophages
[88]. Based on microarray data obtained from primary
mouse macrophages cultured with IL-4, we found that
the expression of 103 lysosomal genes was dependent on
Stat6, reflecting 40% of the known lysosomal proteome
and 54% of lysosomal genes expressed in this cell type;
45 of these genes have been associated with human dis-
eases [89]. Of particular interest is the role of Stat6 in
controlling the vacuolar H+ ATPase that, by virtue of
maintaining the acidic pH in the endo/lysosomal system,
is pivotal to all aspects of lysosomal function [90]. Of 15
different subunits and associated factors that make up
the vacuolar H+ ATPase [90,91], 14 were found to be
controlled by Stat6, and three subunits (encoded by
Atp6v0a1, Atp6v0d2 and Atp6v1b2) were among the
lysosomal genes most strongly induced by IL-4.
Previous studies have shown that IL-4 increases the
expression of the lysosomal proteases cathepsin L and S
in mouse macrophages and of cathepsin S in human
bronchial and conjunctival epithelial cells [92-94]; how-
ever, the transcription factor responsible for this regula-
tion had not yet been identified. Through analysis of
microarray data we found that in mouse macrophages
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somal protease genes, and in 7 of these cases (Ctsk, Ctsl,
Ctso, Ctsz, Mmp13, Scpep1, Tpp1) the IL-4 effect was
dependent on Stat6. In total, the IL-4/Stat6 system was
found to control the expression of 39% of known lyso-
somal hydrolases, a group that in addition to proteases,
include glycosidases, lipases and other degradative en-
zymes. Genes involved in vesicular targeting to lyso-
somes and in the movement of substances across the
lysosomal membrane are also regulated by IL-4/Stat6.
These effects are likely to contribute to the heightened
influx of endocytic substrates and the increased capacity
for lysosomal degradation that have previously been ob-
served in IL-4 treated macrophages [94-96].
Alternatively activated macrophages have been impli-
cated in tissue repair [97], and we speculate that IL-4/
Stat6-mediated expression of lysosomal enzymes may
facilitate the repair-associated turnover of extracellular
matrix, for example through secretion of acidic hydro-
lases into the extracellular space [20,98], or through
intracellular digestion of phagocytosed collagen fibrils
[99]. In support of this model, the lysosomal genes
that are most strongly affected by IL-4 and Stat6 in
macrophages, encoding cathepsins L and K, tartrate-
resistant acid phosphatase, collagenase-3 and vacuolar
H+ ATPase, have all been shown to play important roles
in extracellular matrix degradation [98,100-102]. Fur-
thermore, Stat6-controlled expression of several lyso-
somal and extracellular proteases has been implicated in
tissue destruction during pulmonary emphysema and is
thought to contribute to the invasiveness of glioma
tumours [103-105].
In wild-type macrophages IL-4 effects a complex re-
programming of gene expression, with similar numbers
of lysosomal genes being induced and suppressed. Stat6,
however, appears to mediate only the activating effects
of IL-4 on lysosomal mRNAs. In macrophages devoid of
Stat6 the induction of lysosomal genes by IL-4 was
blocked or severely reduced. On the other hand, in
Stat6−/− cells the suppressive effects of IL-4 remained
largely unchanged, pointing to an IL-4 induced signaling
branch that operates independently of Stat6. Similar
interdigitation of IL-4 and Stat6 signaling has been
observed in the context of Th2 differentiation [106,107].
Unexpectedly, the expression of 82 lysosomal genes was
reduced by IL-4 in Stat6-deficient, but not in wild-type
cells. Stat6 thus acts both to mediate increased expression
as well as to counteract an unknown, inhibitory pathway
that is triggered by IL-4. These results reveal that the role
of Stat6 in this context is significantly broader than might
have been expected from the number of IL-4 induced genes
alone. The mechanism behind this effect is not yet known.
Binding of Stat6 to affected promoters might for example
block access or regulation by IL-4-induced inhibitoryfactors, compensate for the loss of other positive regulators,
or counter the effects of repressive epigenetic alterations.
Stat6 deficiency in mouse T cells has been shown to cause a
marked increase of trimethylated lysine-27 on histone 3
(H3K27me3), indicating that Stat6 supports transcription in
part by antagonizing inhibitory chromatin modifications
[106]. However, to what degree Stat6 exerts this effect in
macrophages still has to be explored in detail.
ChIP data show that about 70% of the lysosomal loci
that are regulated by Stat6 in macrophages have nearby
Stat6 binding sites, indicating that Stat6 is likely exerting
proximal effects in directing the expression of these tar-
gets. A similar number of Stat6 sites near lysosomal
genes have been identified in a ChIP-seq analysis in
mouse Th2 cells; however, very few of these genes were
induced on the mRNA level [106]. While phosphoryl-
ation on tyrosine 641 is sufficient to allow the binding of
Stat6 dimers to cognate DNA elements, Stat6 is unable
to activate transcription on its own [106-108], and it
must cooperate with other proteins to promote gene ex-
pression [61]. In this context, activating chromatin mod-
ifications are likely to be important, as most Stat6 peaks
overlap with regions of histone H3 acetylation, and the
most strongly regulated Stat6 targets experience exten-
sive expansions of H3K27ac marks in an Il-4 and Stat6-
dependent manner. Exactly what additional factors are
involved in IL-4/Stat6-controlled lysosomal gene expres-
sion, and whether they act in concert with or down-
stream of Stat6 remains to be studied.
Conclusions
Understanding how the structure and function of organ-
elles are molded during embryonic development and differ-
entiation is a major goal of cell and developmental biology.
The aim of this study was to identify transcriptional net-
works that are associated with the re-programming specif-
ically of lysosome-related genes. Through large-scale
analyses of published microarray data we identified more
than 50 DNA-binding transcription factors whose expres-
sion correlates with significant numbers of lysosomal genes.
Affiliations identified in this manner indicate that mRNAs
for lysosomal genes are frequently modulated in concert
with regulators that are active during of differentiation, de-
velopment, interferon signaling and oxidative stress, sug-
gesting broad re-programming of lysosomal genes in these
contexts. Depending on network structure, expression of
transcription factors can correlate with their downstream
target genes, and for most of the regulators identified here
such directing roles in lysosomal gene control remains to
be explored. However, Stat6, the strongest candidate emer-
ging from our correlation analysis, was clearly identified as
an upstream regulator for a large number of lysosomal
genes in IL-4 treated mouse macrophages. According to
the effects of IL-4, lysosomal genes can be grouped into
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egory I are induced by IL-4 through a Stat6-dependent
mechanism; genes in category II tend to be suppressed by
IL-4, but this effect is negated in the presence of Stat6; cat-
egory III genes are suppressed by IL-4 through a pathway
operating independently of Stat6. In summary, this work il-
luminates the principal contexts of lysosomal gene regula-
tion, identifies a novel pathway of lysosomal gene control
and advances understanding of the cell and molecular biol-
ogy of alternative macrophage differentiation.
Methods
Materials
Cell culture media were from PAA Laboratories (Yeovil,
UK) and fetal bovine serum (FBS) was from Sigma
Aldrich (Gillingham, UK).Figure 9 Principal mechanisms of lysosomal gene regulation by
IL-4 and Stat6. Analyses of gene expression data from wild-type
and Stat6-deficient mouse macrophages (Additional file 9 and
Figure 5) support a model in which lysosomal genes are regulated
through three main mechanisms. The expression of lysosomal
genes in category I (n = 42) is induced by IL-4 in a pathway that
depends on Stat6. Category II genes (n = 82) are suppressed by IL-4 in
Stat6-deficient cells, but are induced or remain unchanged in wild-type
cells, which points to IL-4 triggering at least two opposing regulatory
signals. Lysosomal genes in catergory III (n = 44) are suppressed by IL-4
in a Stat6-independent manner. The mechanisms by which IL-4
suppresses lysosomal gene expression in this system are
currently unknown.Expression correlation analyses
All data manipulations and calculations were per-
formed with custom Unix/Linux or R version 2..0 scripts
[109]. 1,517 microarray data series based on Affymetrix
mouse genome 430 2.0 arrays (Mouse_430_2; Geo plat-
form accession number GPL1261) and 1,744 data series
based on Affymetrix Human Genome U133 Plus 2.0
arrays (HG_U133_Plus2; GEO platform accession num-
ber GPL570), each containing at least 6 samples, were
downloaded from the NCBI GEO ftp site [37]. The
data in each file were reduced to high-quality probe
sets attributable to single, full-length mRNAs (labeled
“grade A” in Affymetrix annotation files; Mouse430_2.
na32.annot.csv and HG_U133_Plus_2.na32.annot.csv).
As the number of probe sets on these platforms varies
for individual targets, values for genes represented by
more than one probe set were averaged, leaving data
for 16,772 mouse and 17,237 human genetic endpoints.
Each dataset was then saved as an R data frame in binary
format for subsequent analyses. Gene expression correl-
ation matrices were calculated using the R ‘cor’ function
(Pearson method).Clustering
Data matrices were subjected to hierarchical clustering
using the R ‘hclust’ function (complete method), and
heat maps were generated with the ‘heatmap.2’ function
from the gplots library [110]. Dendrograms were split
into clusters using the R ‘cutree’ function.Microarray data analysis
For the analyses that resulted in Additional file 9 and
Figure 5, raw data (cel files) were background-corrected
and normalized using the Bioconductor GCRMA package
[111]. Only probe sets based on full-length cDNAs,
assigned to a single gene and annotated as “grade A” ac-
cording to Affymetrix annotation files were used for further
analyses. Probe IDs were replaced with gene symbols, and
data for genes represented by more than one probe set
were averaged. Genes with average expression values of less
than one standard deviation (SD) under all four conditions
were considered not expressed and excluded. In the
remaining matrix (10,232 genes) values below 1 SD were
set to 1 SD. Variances between pairs of triplicate data were
then compared with an F test (R ‘var.test’ function); if the
resulting p value was greater than 0.05, an unpaired Stu-
dent’s t test was performed, otherwise Welch’s t test was
used (R ‘t.test’ function). The p values returned by the t
tests were corrected for multiple hypothesis testing using
the false discovery rate method (R ‘p.adjust’ function). Log
(base 2) fold changes were set to zero when p values
returned by p.adjust were greater than 0.05.
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GO annotations are based on lists that we downloaded
from the AmiGO gene ontology site [38]. Lists of known
transcription regulators were based on a compilation
published by Ravasi et al. [39] that was extended based
on recent GO annotations (GO:0000981, GO:0000982,
GO:0000983, GO:0000988, GO:0000989, GO:0001010,
GO:0001011, GO:0001071, GO:0001076, GO:0001087,
GO:0001133, GO:0003700, GO:0003705, GO:0004879).
Lists of lysosomal genes were based on combined mouse
and human annotations for the GO terms ‘lysosome’
(GO:0005764) and ‘vacuole’ (GO:0005773), which were
extended based on reviews of the lysosomal proteome
[38,43,44]. In some cases gene lists were further modi-
fied by removing genes for which no high-quality data
were available in the given data set.
Analysis of published ChIP-seq data
Files with peak coordinates in bed format were down-
loaded from the NCBI GEO depository [GEO:GSE38379].
The data were annotated using the Bioconductor ChIP-
peakAnno package (version 2.6.1.) [112], and peaks were
graphically aligned to genomic loci using R code based
on the Gviz (version 1.2.1.), GenomicFeatures (version
1.10.2.) and Lattice packages [113-115].
Promoter sequence analysis
Promoter sequences ± 2 kb relative to transcription start
sites were searched for perfect matches to the Stat6 con-
sensus binding motif (TTCNNNNGAA) using the RSAT
tool (DNA-pattern method, 0 substitutions) [116,117].
Mouse husbandry
Stat6-deficient mice (C.129S2-Stat6tm1Gru/J) were ob-
tained from Jackson Laboratories [118]. Animals were
housed in Tecniplast blue line IVC cages at a negative
pressure of 25pa with 75 air changes an hour and fed a
standard CRM diet (SDS Diets Services, Essex, UK).
Work involving mice was approved by the UK Home
Office and the University of Debrecen Medical and
Health Science Center Ethics Committee (license num-
ber 120/2009/DE MAB), respectively.
Cell culture
For studies performed in London, cells were cultured at
37°C in an atmosphere of 5% CO2. Medium A refers to
RPMI supplemented with 10% FBS, 50 U/ml penicillin
and 50 μg/ml streptomycin. To obtain bone marrow
macrophages, the femurs of mice were submersed in
PBS, crushed with hemostats, filtered through 70-μm
cell strainers (BD Falcon), washed with PBS and plated
in medium A on untreated 10-cm Petri dishes overnight.
Unattached cells were then set up in 6-well plates at
5.5x106 cells per well in medium B plus 20 ng/mlmurine recombinant M-CSF (Peprotech) plus or minus
murine recombinant IL-4 (Peprotech).
For work performed in Debrecen, cells were isolated
and differentiated as previously described [119]. Bone-
marrow was flushed from the femur of wild-type
C57BI6/J male animals. Cells were purified through a
Ficoll-Paque gradient (Amersham Biosciences, Arlington
Heights, IL) and cultured in DMEM containing 20%
endotoxin-reduced fetal bovine serum and 30% L929
conditioned medium for 5 days.
RNA analysis by qPCR
Total RNA was isolated using Trizol reagent (Invitrogen)
and 1–2 μg used as template in 20-μl reverse transcription
reactions using Tetro Reverse Transcriptase (Bioline) or a
Superscript III CellDirect cDNA synthesis kit (Invitrogen).
Quantitative PCR reactions were performed in a Bio-Rad
CFX96 thermocycler and set up using a Platinum SYBR
Green qPCR Supermix (Invitrogen) or SYBR green dye
from Diagenode, each in a total volume of 10 μl containing
0.5 μl cDNA and 200 nM primers. Primer sequences are
given in Additional file 13. Standard curves with serial tem-
plate dilutions were included with each run.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described [120]
with minor modifications. Briefly, cells were cross-
linked with DSG (Sigma) for 30 minutes and then with
formaldehyde (Sigma) for 10 minutes. After fixation
chromatin was sonicated with a Diagenode Bioraptor
to generate 200-1000 bp fragments. Chromatin was
immunoprecipitated with pre-immune IgG (Millipore,
12–370), or with a polyclonal antibody against STAT6
(Santa Cruz, sc-981). Chromatin antibody complexes
were precipitated with anti-IgA paramagnetic beads
(Life Technologies). After 6 washing steps complexes
were eluted and the crosslinks reversed. DNA frag-
ments were column purified (Qiagen, MinElute). DNA
was quantified with a Qubit fluorometer (Invitrogen).
Immunoprecipitated DNA was quantified by qPCR and
normalized to values obtained after amplification of
unprecipitated (input) DNA.
Graphics
Graphics were generated with custom R scripts, in some
cases using extensions provided by the gplots, ggplot2
and other packages as indicated [110,121]. R-generated
graphic files in portable document format (PDF) were
further edited in Adobe Illustrator.
Availability of supporting data
A searchable database with the results of transcription
factor gene expression correlation analyses is available at
http://genecan.sgul.ac.uk.
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Additional file 1: Expression correlation between membrane
biogenesis genes and known transcription factors. The data pertain
to Figure 1 of the main article, and calculations were performed as
detailed in the accompanying legend. (Worksheet 1, “Cholesterol
biosynthesis”) Column A lists 19 genes encoding enzymes in the
cholesterol biosynthesis pathway that were used as a reference set [6].
Column C lists NCBI GEO accession numbers of 472 Mouse430_2-based
gene expression data series that had been selected based on a minimum
average coefficient of correlation among the 19 reference genes of 30%.
The genes in Column E are based on a list of known transcription factors
(see Methods). Values in Column G represent average Pearson correlation
coefficients calculated between the corresponding transcription factor in
Column E and the reference genes from Column A across the data series
listed in Column C. Column F indicates whether the gene encodes a
DNA-binding protein according to GO annotations (GO:0003677). Tran-
scription factor genes are listed according to correlation values in de-
scending order. (Worksheet 2, “ER”) Column A lists 95 highly correlated ER
genes that have been selected as detailed in the legends to Figure 1b
and Additional file 3, after removing known transcription factors. Column
C lists NCBI GEO accession numbers of 247 Mouse430_2-based gene
expression data series that had been selected based on a minimum
average coefficient of correlation among the 95 reference genes of
30%. Columns E-G contain correlation data for transcription factor
genes as detailed above.
Additional file 2: Matrix of expression correlations among ER genes
in mouse. This supplement pertains to Figure 1b and Additional file 3.
Data were generated as described in the accompanying legends.
Tab-delimited.
Additional file 3: Gene expression correlation analysis identifies
distinct subsets of ER genes. These data pertain to Figure 1b of the
main article. Pearson correlation coefficients across 1,435 Mouse430_2-
based microarray datasets were calculated among 778 ER genes. The
gene list was based on a set downloaded from the AmiGO gene
ontology database (GO:0005783) and modified by removing genes also
associated with the Golgi (GO:0005794) or lysosomes (GO:0005764). The
resulting data matrix (Additional file 2) was subjected to hierarchical
clustering as described in Methods. The cluster with the largest average
(x = 0.101), consisting of 97 ER genes (listed in Additional file 1),
is highlighted in red.
Additional file 4: Genome-wide expression correlation analyses for
mouse and human SREBF2 and XBP1. (Worksheet 1, “Mouse”) Pearson
correlations were averaged across the indicated number (n) of
Mouse430_2-based datasets between the transcription factors Srebf2 or
Xbp1 and 16,771 other named genes for which high-quality data were
available. (Worksheet 2, “Human”) Pearson correlations between human
SREBF2 or XBP1 and 17,236 other named genes averaged across the indi-
cated number (n) of HG_U133_Plus2-based datasets.
Additional file 5: Transcription factors whose expression correlates
with lysosomal genes. Average expression correlations were calculated
for each of 1412 human and 1066 mouse DNA-binding transcription fac-
tors across Affymetrix Mouse_430_2 and HG_U133_Plus2 arrays, respec-
tively. We interrogated 1548 mouse and 1838 human datasets, but only
those datasets with a minimum coefficient of variation of 5% for the re-
spective reference gene were used for analyses (average number of data-
sets analyzed per gene, n=1061; range, 761-1281). In each case the 500
highest-ranking correlators were analyzed for GO term enrichment using
a script based on the Bioconductor GOstats package [41]. The cutoff for p
values was 0.001. The results were searched for the terms ‘lysosome’ or
‘vacuole’ and further filtered for genes encoding DNA-binding proteins
that scored positive for both mouse and human data. GO term enrich-
ment statistics are shown for the resulting 49 DNA-binding transcription
factors. TF, transcription factor; ExpCount, expected number of genes in
the selected 500-member list to be annotated with the respective GO
term; Count, actual number of genes annotated with the GO term; Size,
maximum number that could have been matched; Pvalue, hypergeo-
metric probability; GO ID, gene ontology identifier. More detailed infor-
mation is available at http://genecan.sgul.ac.uk.Additional file 6: Matrix of expression correlations among
lysosomal genes in mouse. This supplement pertains to Figures 2 and
3. Data were generated as described in the accompanying legends.
Tab-delimited.
Additional file 7: On each worksheet Column A lists lysosomal
genes for the indicated cluster from Figure 2. Column C lists NCBI
GEO accession numbers of Mouse430_2 or HG_U133_Plus2-based gene
expression data series that had been selected based on a minimum
average coefficient of correlation among the reference genes of 30%.
Values in Column G represent average Pearson correlation coefficients
calculated between the corresponding transcription factor in Column E
and the reference genes from Column A across the data series listed in
Column C. Column F indicates whether the gene encodes a DNA-binding
protein according to GO annotations (GO:0003677). Transcription factor
genes are listed according to correlation values in descending order.
Additional file 8: Correlation of Stat6 with lysosomal genes.
(Worksheet 1, “Correl. Mouse”) Average expression correlations across
1,093 datasets were calculated between mouse Stat6 and genes
represented on Mouse_430_2 arrays as described in the legend to
Additional file 4. (Worksheet 2, “Correl. Human”) Average expression
correlations across 1,122 datasets were calculated between human STAT6
and genes represented on HG_U133_Plus2 arrays as described in the
legend to Additional file 4. (Worksheet 3, “GSEA Mouse”) The correlation-
ranked gene list from Worksheet 1 was analyzed for GO term enrichment
using the GSEA tool [57]. Gene set reference files in gene matrix trans-
posed (gmt) format were generated by reformatting lists, downloaded
from the AmiGO website, containing all mouse and human GO associa-
tions (all gene product types and data sources) [38]. Column J lists ‘lead-
ing-edge’ lysosomal genes as returned by GSEA; genes common to both
the mouse and human leading edges are shown in red; leading-edge
lysosomal genes bound by Stat6 according to reference [106] are boxed.
(Worksheet 4, “GSEA Human”) The correlation-ranked gene list from Work-
sheet 2 was analyzed for GO term enrichment using the GSEA tool as in
Worksheet 3. (Worksheet 5, “GOstats Mouse”) The 500 highest-ranking
genes in Worksheet 1 were analyzed for GO term enrichment using a
custom R script based on the Bioconductor GOstats package [41].
(Worksheet 6, “GOstats Human”) The 500 highest-ranking genes in Work-
sheet 2 were analyzed for GO term enrichment as in Worksheet 5.
Additional file 9: Effects of Stat6 and IL-4 on lysosomal gene
expression in mouse bone marrow macrophages. The data pertain
to Figure 5 of the main article, and calculations were performed as
detailed in the accompanying legend and in Methods. Values
indicate log (base 2) fold changes of lysosomal genes as determined
by gene expression profiling. Genes are color-coded according to GO
annotations. Antigen processing and presentation, GO:0019882; glycosidases,
GO:0016798; peptidases, GO:0008233; other hydrolases, GO:0016787; vesicular
transport, GO:0016192; vacuolar H+ ATPase, GO:0016471.
Additional file 10: Stat6-bound loci are statistically enriched for
genes encoding lysosomal proteins. This analysis is based on publicly
available ChIP-seq data as described in the legend to Figure 7. A file with
peak coordinates in bed format was downloaded from the NCBI GEO
depository [GEO:GSM1022305], and peaks were annotated as described in
Methods. We only considered peaks whose centers were located within
5kb of transcription start sites of genes for which both HGNS gene sym-
bols and Entrez gene IDs were available. The resulting list of 4,520 gene
symbols was analyzed for GO set enrichment using the Bioconductor
GOstats package [41]. The reference set consisted of 23,563 unique gene
symbols based on a list of mouse GO annotations (version 1.79) from the
Mouse Genome Information (MGI) site for which Entrez gene IDs were
also available [122].
Additional file 11: Stat6 binding to lysosomal loci verified by ChIP-
PCR. Bone marrow-derived macrophages from wild-type and Stat6-
deficient mice were cultured in the presence of M-CSF for five days and
then switched to media ± recombinant IL-4 for 30 minutes. Chromatin
was crosslinked, fragmented and immunoprecipitated with control IgG
(left panels) or anti-Stat6 (right panels) as described in Methods. The
immunoprecipitated DNA was used as template for qPCR reactions to
quantify selected Stat6 peak regions. Coordinates of PCR fragments are
(mouse genome build mm9): Arg1, chr10:24650166-24650215; Plekhf1,
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chr4:19821892-19821947; Atp6v0a1, chr11:100856194-100856250;
Atp6v1b2, chr8:71615039-71615173; Ctsl, Chr13:64503469-64503600.
Additional file 12: Stat6 binds to active chromatin regions. Analyses
are based on publicly available ChIP-seq data deposited by Ostuni et al.
[58]. Peak coordinates in bed format were downloaded from the NCBI
GEO site [GEO:GSM1022256, GSM1022257, GSM1022258, GSM1022259,
GSM1022260, GSM1022261, GSM1022262, GSM1022263, GSM1022264,
GSM1022265, GSM1022266, GSM1022267, GSM1022297, GSM1022298,
GSM1022299] and analyzed with the ChipPeakAnno package [112].
Columns A-C list the merged coordinates of 196 Stat6 peaks selected
according to three criteria: (i) Stat6 peaks overlapped in all of three inde-
pendent data sets obtained after growth of mouse macrophages with
IL-4 for 1, 2 and 4 hours [GEO:GSM1022297, GSM1022298, GSM1022299];
(ii) peaks were filtered to exclude those located farther than 5kb from the
nearest transcription start site; (iii) we further selected peaks close to
genes annotated as encoding lysosomal proteins. Peak names in column
E correspond to those in GSM1022299. Peaks were annotated with gene
identifiers using information obtained through the BioMart server [123].
Columns H-S indicate whether the Stat6 peaks overlap with peaks
obtained with antibodies against H3K26ac (columns H-K), H3K4me1
(columns L-O) or Pu.1 (columns P-S), using chromatin from wild-type
or Stat6-deficient macrophages grown ± IL-4 for 4 hours as indicated
in the column headers [58].
Additional file 13: Oligonucleotides used for qPCR. Primers were
designed based on sequence information obtained through the NCBI
Entrez Gene server [124] using the Primer-BLAST software tool [125].
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